Decreased expression of STING predicts poor prognosis in patients with gastric cancerShushu Song, Jianxin Gu, Weicheng Wu et al.|Scientific Reports|2017Cited by 224
The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junctionZhaoqing Tang, Yihong Sun|Nature Communications|2022Cited by 82
NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric CancerYuehong Cui, Tianshu Liu, Qian Li et al.|Frontiers in Oncology|2021Cited by 79